Literature DB >> 26004156

The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.

Erdinç Dursun1, Duygu Gezen-Ak2, Haşmet Hanağası3, Başar Bilgiç3, Ebba Lohmann3, Sibel Ertan4, İrem L Atasoy5, Merve Alaylıoğlu5, Ömür Selin Araz5, Burak Önal6, Ayşegül Gündüz4, Hülya Apaydın4, Güneş Kızıltan4, Turgut Ulutin5, Hakan Gürvit3, Selma Yılmazer7.   

Abstract

Alzheimer's disease (EOAD, LOAD), mild cognitive impairment (MCI), Parkinson's disease (PD) and healthy controls were included to determine the serum interleukin-1s (IL-1α, IL-1β), IL-6 and alpha-2-macroglobulin (α2M) levels using ELISA. IL-6 might be a significant contributor to the inflammatory response in LOAD. The MCI data indicate that IL-1s, α2M and BDNF are somehow related, and this relationship might allow MCI patients to be more similar to the healthy controls. A correlation analysis of multiple biomarkers in different neurodegenerative disorders might be more useful than determining the levels of a single cytokine in a single disorder.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alpha-2 macroglobulin (α2-macroglobulin); Alzheimer's disease; Biomarker; Brain derived neurotrophic factor (BDNF); Heat shock protein 90 (Hsp90); Interleukin 1 alpha (IL-1α); Interleukin 1 beta (IL-1β); Interleukin 10 (IL-10); Interleukin 6 (IL-6); Mild cognitive impairment (MCI); Parkinson's disease (PD); Tumor necrosis factor alpha (TNFα)

Mesh:

Substances:

Year:  2015        PMID: 26004156     DOI: 10.1016/j.jneuroim.2015.04.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  75 in total

1.  Adult neurogenesis and neurodegenerative diseases: A systems biology perspective.

Authors:  Emrin Horgusluoglu; Kelly Nudelman; Kwangsik Nho; Andrew J Saykin
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-02-16       Impact factor: 3.568

2.  Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer's disease patients.

Authors:  Erdinç Dursun; Merve Alaylıoğlu; Başar Bilgiç; Haşmet Hanağası; Ebba Lohmann; Irem L Atasoy; Esin Candaş; Ömür Selin Araz; Burak Önal; Hakan Gürvit; Selma Yılmazer; Duygu Gezen-Ak
Journal:  Neurol Sci       Date:  2016-06-29       Impact factor: 3.307

3.  Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer's disease spectrum.

Authors:  Ashley Swanson; A A Willette
Journal:  Brain Behav Immun       Date:  2016-07-18       Impact factor: 7.217

Review 4.  Mercury and Alzheimer's disease: a look at the links and evidence.

Authors:  Jihan Azar; Mohamed H Yousef; Hassan A N El-Fawal; Anwar Abdelnaser
Journal:  Metab Brain Dis       Date:  2021-01-07       Impact factor: 3.584

5.  Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.

Authors:  Debra E Lyon; Ronald Cohen; Huaihou Chen; Debra L Kelly; Nancy L McCain; Angela Starkweather; Hyochol Ahn; Jamie Sturgill; Colleen K Jackson-Cook
Journal:  J Neuroimmunol       Date:  2016-11-13       Impact factor: 3.478

6.  Klotho Ameliorates Cellular Inflammation via Suppression of Cytokine Release and Upregulation of miR-29a in the PBMCs of Diagnosed Alzheimer's Disease Patients.

Authors:  Mohsen Sedighi; Tourandokht Baluchnejadmojarad; Soudabeh Fallah; Nariman Moradi; Siamak Afshin-Majdd; Mehrdad Roghani
Journal:  J Mol Neurosci       Date:  2019-06-13       Impact factor: 3.444

Review 7.  Glucocorticoid-Induced Leucine Zipper in Central Nervous System Health and Disease.

Authors:  Mythily Srinivasan; Debomoy K Lahiri
Journal:  Mol Neurobiol       Date:  2016-11-26       Impact factor: 5.590

8.  Cerebrospinal Fluid C-Reactive Protein in Parkinson's Disease: Associations with Motor and Non-motor Symptoms.

Authors:  Hossein Sanjari Moghaddam; Zahra Valitabar; Amir Ashraf-Ganjouei; Mahtab Mojtahed Zadeh; Farzaneh Ghazi Sherbaf; Mohammad Hadi Aarabi
Journal:  Neuromolecular Med       Date:  2018-07-06       Impact factor: 3.843

9.  Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial.

Authors:  Mengyue Li; Wen Li; Yiming Gao; Yongjie Chen; Dong Bai; Jinxi Weng; Yue Du; Fei Ma; Xinyan Wang; Huan Liu; Guowei Huang
Journal:  Eur J Nutr       Date:  2020-08-28       Impact factor: 5.614

Review 10.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.